Glutathione (IV/IM) vs TUDCA
A side-by-side research comparison of Glutathione (IV/IM) and TUDCA across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | Glutathione (IV/IM) | TUDCA |
|---|---|---|
| Full name | L-Glutathione (Reduced, Injectable) | Tauroursodeoxycholic Acid |
| Category | Detox & Antioxidant | Detox & Antioxidant |
| Status | Compounded / Prescription | OTC supplement / Investigational |
| Mechanism | Directly conjugates with toxins, heavy metals, and reactive oxygen species via glutathione S-transferases. Regenerates vitamins C and E. Maintains thiol redox status. Supports Phase II liver detoxification. | Acts as a chemical chaperone that reduces endoplasmic reticulum (ER) stress, inhibits apoptosis, protects mitochondria, improves bile flow and solubility, and provides neuroprotective and cytoprotective effects. |
| Molecular weight | 307.32 Da | 571.81 Da |
| Half-life | ~2-3 hours (IV bolus) | Variable (enterohepatic recirculation) |
| Bioavailability | 100% (IV); ~60% (IM); ~5-10% (oral) | Moderate oral |
| Typical dose | 600-2000 mg IV push or 200-600 mg IM | 250-500 mg per day |
| Frequency | 1-3x weekly | 1-2x daily |
| Route | Intravenous push or intramuscular injection | Oral capsule |
Glutathione (IV/IM) reported benefits
- Heavy metal detoxification
- Liver support and protection
- Skin brightening/lightening
- Immune system enhancement
- Mitochondrial protection
- Anti-aging (oxidative stress reduction)
TUDCA reported benefits
- Liver protection and enzyme normalization
- Improved bile flow
- Reduced ER stress
- Mitochondrial protection
- Neuroprotective potential
- Gut barrier support
Related comparisons
Research and educational reference only. Not medical advice.